Evaluation of an online training tool for scoring programmed cell death ligand-1 (PD-L1) diagnostic tests for lung cancer

BACKGROUND: Numerous studies indicate that higher tumour programmed cell death ligand-1 (PD-L1) expression is associated with greater response to anti-programmed cell death-1 (PD-1)/PD-L1 immunotherapy in non-small cell lung cancer (NSCLC). In the era of precision medicine, there is a need to provid...

Descripción completa

Detalles Bibliográficos
Autores principales: Jasani, Bharat, Bänfer, Gudrun, Fish, Rebecca, Waelput, Wim, Sucaet, Yves, Barker, Craig, Whiteley, Jessica L., Walker, Jill, Hovelinck, Rudy, Diezko, Rolf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7164334/
https://www.ncbi.nlm.nih.gov/pubmed/32303234
http://dx.doi.org/10.1186/s13000-020-00953-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7164334/
https://www.ncbi.nlm.nih.gov/pubmed/32303234
http://dx.doi.org/10.1186/s13000-020-00953-9

Ejemplares similares